Reduced tissue sodium content is related to improvement of vascular function in patients with chronic heart failure treated with the SGLT2 inhibitor empagliflozin - Kolwelter, Julie; Kannenkeril, Dennis; Linz, Peter; Jung, Susanne; Nagel, Armin Michael; Bosch, Agnes; Ott, Christian; Bramlage, P.; Uder, Michael; Achenbach, Stephan; Schmieder, Roland (EUROPEAN HEART JOURNAL, 2021)
CRIS-Team WoS Importer:2021-12-10